Prevalence of adverse effects and efficacy of anticoagulant therapy with Dabigatranversus Warfarin in patients with non-valvular atrial fibrillation in the cardiology

Journal Title: Más Vita - Year 2022, Vol 4, Issue 4

Abstract

Introduction: Atrial fibrillation (AF) is the most frequent cardiac arrhythmia, affecting approximately 2% of the general population and its prevalence increases with age and the presence of risk factors; In addition, it can be associated with different comorbidities such as: AHT, DM, HF, AMI, among others. Objective:To determine the prevalence of adverse effects and efficacy of anticoagulant therapy with Dabigatran versus Warfarin in patients with non-valvular atrial fibrillation at the HTMC, from January 2014 to January 2018. Materials and methods: It is a retrospective study. ,analytical and descriptive; the universe was made up of 500 HTMC patients with a diagnosis of atrial fibrillation. The data collection instrument was through the IESS AS400 system, in which the information was collected from the patients' medical records and stored in Microsoft Excel. A sample was obtained, according to the inclusion criteria, giving a total of 209 patients, divided into two groups, the first of 106 patients medicated with Warfarin and the second of 103 patients who were medicated with Dabigatran. Results:The results of the assessment of thromboembolic and hemorrhagic risk were obtained, based on the CHADS2VASC and HAS BLED scales, respectively. The patients presented the samecomorbidities, there was no statistically significant difference between the different age and gender groups, neither for smoking and obesity; on the contrary, if there was a statistically significant difference for alcoholism, there is probably greater exposure to this cardiovascular risk factor in one of the groups; for heart failure, this would indicate a greater presence of heart failure in one of the groups.Conclusion:It was concluded that both groups had the same probability of presenting bleeding events through the HAS BLED score; however, the statistically significant P values for the different types of bleeding show that there is a higher prevalence of bleeding in one group than in another. It was determined that the patients medicated with Warfarin had a higher prevalence of bleeding during the 4 years of the study, unlike the group of patients medicated with Dabigatran

Authors and Affiliations

Luis Armando Rosado Vargas, André José Díaz Cabezas, Arianna Marina Navarrete Ponce, Fabio Alexander Macías Silva

Keywords

Related Articles

First line antibiotic treatment for minor diabetic foot injuries

Introduction: The diabetic foot is one of the complications that occurs most frequently in patients with type 2 diabetes; initial antibiotic treatment is an option to prevent disease progression to amputation of part or...

Factors that influence the nutritional status of children aged 1-5 in Ecuador

Introduction: Joint efforts have been made to search for strategies on nutrition in Ecuador, which allow the analysis of the information collected in censuses and surveys, in order to establish the indicator factors of r...

Triggering factors for abandonment of antiphimic treatment. District 09d13. 2016 - 2019

defined as the continuous absence of the patient to antituberculous therapy for a month or more, represents an excess of public health spending. It is one of the public health problems most reported and worldwide...

Validation of an Instrument to Evaluate the Prevalence and Consequences of AdolescentPregnancy in the Area of Influence of the Macuma Health Center in the Shuar Indigenous Zone

There are several studies on teenage pregnancy, risk factors, consequences of pregnancy, prevalence, but none has a validated document to collect relevant information to address the problem. Objectiv...

Design and validation of the quantitative and qualitative instruments 0-6 lme to deter-mine the risk factors of the interruption of exclusive breastfeeding

Exclusive breastfeeding (EBF) has been considered a healthy practice, since it contributes essential nutrients for the health and growth of the child. From this perspective, it considered necessary t...

Download PDF file
  • EP ID EP711827
  • DOI https://doi.org/10.47606/ACVEN/MV0170
  • Views 60
  • Downloads 0

How To Cite

Luis Armando Rosado Vargas, André José Díaz Cabezas, Arianna Marina Navarrete Ponce, Fabio Alexander Macías Silva (2022). Prevalence of adverse effects and efficacy of anticoagulant therapy with Dabigatranversus Warfarin in patients with non-valvular atrial fibrillation in the cardiology. Más Vita, 4(4), -. https://europub.co.uk/articles/-A-711827